Jennison Associates’s Rocket Pharmaceuticals RCKT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-114,580
| Closed | -$764K | – | 627 |
|
|
2025
Q1 | $764K | Buy |
114,580
+44,276
| +63% | +$295K | ﹤0.01% | 508 |
|
|
2024
Q4 | $884K | Buy |
70,304
+29,564
| +73% | +$372K | ﹤0.01% | 501 |
|
|
2024
Q3 | $752K | Buy |
40,740
+10,162
| +33% | +$188K | ﹤0.01% | 512 |
|
|
2024
Q2 | $658K | Buy |
30,578
+3,795
| +14% | +$81.7K | ﹤0.01% | 527 |
|
|
2024
Q1 | $722K | Buy |
26,783
+903
| +3% | +$24.3K | ﹤0.01% | 528 |
|
|
2023
Q4 | $776K | Sell |
25,880
-1,756
| -6% | -$52.6K | ﹤0.01% | 521 |
|
|
2023
Q3 | $566K | Sell |
27,636
-6,043
| -18% | -$124K | ﹤0.01% | 533 |
|
|
2023
Q2 | $669K | Buy |
+33,679
| New | +$669K | ﹤0.01% | 530 |
|
|
2018
Q1 | – | Sell |
-1,366,853
| Closed | -$3.57M | – | 691 |
|
|
2017
Q4 | $3.57M | Sell |
1,366,853
-189,861
| -12% | -$495K | ﹤0.01% | 504 |
|
|
2017
Q3 | $2.77M | Buy |
+1,556,714
| New | +$2.77M | ﹤0.01% | 517 |
|
|
2017
Q1 | – | Sell |
-1,980,842
| Closed | -$12.1M | – | 758 |
|
|
2016
Q4 | $12.1M | Buy |
1,980,842
+4,690
| +0.2% | +$28.6K | 0.01% | 461 |
|
|
2016
Q3 | $18.7M | Buy |
1,976,152
+27,764
| +1% | +$263K | 0.02% | 422 |
|
|
2016
Q2 | $14.5M | Sell |
1,948,388
-1,553
| -0.1% | -$11.6K | 0.02% | 431 |
|
|
2016
Q1 | $14.4M | Buy |
1,949,941
+30,089
| +2% | +$223K | 0.02% | 434 |
|
|
2015
Q4 | $21.8M | Buy |
1,919,852
+21,028
| +1% | +$238K | 0.02% | 412 |
|
|
2015
Q3 | $17.8M | Buy |
1,898,824
+424,369
| +29% | +$3.99M | 0.02% | 446 |
|
|
2015
Q2 | $7.23M | Buy |
1,474,455
+473,537
| +47% | +$2.32M | 0.01% | 518 |
|
|
2015
Q1 | $5.43M | Buy |
+1,000,918
| New | +$5.43M | 0.01% | 508 |
|